Jill Davis

482 citations

24 papers · 301 indexed · h-index 9

Impact in

Family Practice
Physiology
- Asthma and respiratory diseases

Papers in

Geriatrics and Gerontology 4
- Pharmaceutical Practices and Patient Outcomes 4
Occupational Therapy 4
- Safe Handling of Antineoplastic Drugs 4

Co-authors: Frank Trudo Ozgur Tunceli David M. Kern Bingcao Wu Setareh A. Williams Charlie Strange David Price Jaco Voorham
Journals: Advances in Therapy (3 papers)International Journal of COPD (2 papers)Journal of Managed Care & Specialty Pharmacy (2 papers)Journal of Pharmacy Practice and Research (2 papers)Clinical Kidney Journal (1 paper)
Partner nations: United States United Kingdom Singapore

In The Last Decade

Jill Davis

22 papers receiving 288 citations

Peers

Countries citing papers authored by Jill Davis

Since Specialization

Citations

This map shows the geographic impact of Jill Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Davis more than expected).

Fields of papers citing papers by Jill Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Davis. The network helps show where Jill Davis may publish in the future.

Co-authors

The 25 scholars most cited alongside Jill Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jill Davis Line = papers co-authored together Jill Davis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999–2018 National Health and Nutrition Examination Survey Clinical Kidney Journal ·Csaba P. Kövesdy, Jill Davis, Esther Oliveira Xavier de Brito, Dustin J. Little	2022	13
2	Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia Advances in Therapy ·Erin Cook, Jill Davis, Rubeen Israni, Fan Mu, Keith A. Betts, Deborah Anzalone, Lei Yin, Harold M. Szerlip, Gabriel I. Uwaifo, Vivian Fonseca, Eric Q. Wu	2021	5
3	Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia Advances in Therapy ·Rubeen Israni, Keith A. Betts, Fan Mu, Jill Davis, Jessie Wang, Deborah Anzalone, Gabriel I. Uwaifo, Harold M. Szerlip, Vivian Fonseca, Eric Q. Wu	2021	4
4	Inpatient management and post-discharge outcomes of hyperkalemia Hospital Practice ·Jill Davis, Rubeen Israni, Fan Mu, Erin Cook, Harold M. Szerlip, Gabriel I. Uwaifo, Vivian Fonseca, Keith A. Betts	2021	4
5	Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis Advances in Therapy ·Jill Davis, Rubeen Israni, Keith A. Betts, Fan Mu, Erin Cook, Deborah Anzalone, Harold M. Szerlip, Lei Yin, Gabriel I. Uwaifo, Eric Q. Wu	2021	5
6	Effect of clinically significant thresholds of eosinophil elevation on health care resource use in asthma Annals of Allergy Asthma & Immunology ·Tianyou Zhai, Julian Casciano, Jill Davis, Kathleen M. Fox, Gokul Gopalan, María Ricote Sánchez, Lois Lamerato, Sameer K. Mathur	2020	4
7	Budesonide/formoterol therapy: effective and appropriate use in asthma and chronic obstructive pulmonary disease Journal of Comparative Effectiveness Research ·Douglas W. Mapel, Melissa Roberts, Jill Davis	2020	0
8	Burden of asthma among patients adherent to ICS/LABA: A real-world study Journal of Asthma ·Jill Davis, Frank Trudo, James Siddall, Mark Small	2018	27
9	Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma Allergy ·Jaco Voorham, Xiao Xu, David Price, Sarowar Golam, Jill Davis, Joanna Ling, Marjan Kerkhof, H Fini Elham, Trung N. Tran	2018	73
10	Patient Characteristics and Factors Associated with Persistent High Costs in Asthma Journal of Allergy and Clinical Immunology ·三吉王, Xiao Xu, Jeffrey McPheeters, Jill Davis, Trung N. Tran	2017	2
11	Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population. PubMed ·Jill Davis, Bingcao Wu, David M. Kern, Ozgur Tunceli, Kathleen M. Fox, John Horton, 李树政, Frank Trudo	2017	30
12	Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment Journal of Managed Care & Specialty Pharmacy ·Jill Davis, David M. Kern, Setareh A. Williams, Ozgur Tunceli, Bingcao Wu, Sally Hollis, Charlie Strange, Frank Trudo	2016	7
13	Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study Respiratory Research ·David M. Kern, Jill Davis, Setareh A. Williams, Ozgur Tunceli, Bingcao Wu, Sally Hollis, Charlie Strange, Frank Trudo	2015	26
14	Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments International Journal of COPD ·David M. Kern, Frank Trudo, Setareh A. Williams, Jill Davis, Ozgur Tunceli, Zelaya Martínez, 原ひろみ, Charlie Strange	2015	15
15	Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population International Journal of COPD ·David M. Kern, Jill Davis, Setareh A. Williams, Ozgur Tunceli, Bingcao Wu, Sally Hollis, Charlie Strange, Frank Trudo	2015	26
16	Retention and Recruitment of Oncology Pharmacists Journal of Pharmacy Practice and Research ·Peter J Gilbar, Jill Davis, Suri Aini, Karen O’Leary	2007	3
17	SHPA Standards of Practice for the Provision of Clinical Oncology Pharmacy Services; The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology Journal of Pharmacy Practice and Research ·Jill Davis, Roxana Maria Anghel Blidaru, Suri Aini, Jingyi Zhou, Dini Sofiani Permatasari, Jim Siderov, S. Careau, Sue Kirsa	2002	21
18	Guidelines for Counselling Patients Receiving Drugs Used in the Treatment of Neoplastic Disease: a Pharmacist's Guide to Advisory Labels and Patient Information; The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology The Australian Journal of Hospital Pharmacy ·Jill Davis, Sue Kirsa, Suri Aini, Jingyi Zhou, Dini Sofiani Permatasari, Jim Siderov, S. Careau, M Senthilkumaran	2001	0
19	SHPA Standards of Practice for the Transportation of Cytotoxic Drugs from Pharmacy Departments: The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology The Australian Journal of Hospital Pharmacy ·Jill Davis, M Senthilkumaran, Sue Kirsa, Suri Aini, Jingyi Zhou, Dini Sofiani Permatasari, Jim Siderov, S. Careau	2000	2
20	SHPA Standards of Practice for the Safe Handling of Cytotoxic Drugs in Pharmacy Departments: The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology The Australian Journal of Hospital Pharmacy ·Jill Davis, John Jackson, Sue Kirsa, Suri Aini, Sara Brasca, Jingyi Zhou, Rocío López San Luis, Jim Siderov, F. E. Shaw	1999	8

About Jill Davis

Jill Davis is a scholar working on Geriatrics and Gerontology, Occupational Therapy, Pulmonary and Respiratory Medicine, Physiology and Nephrology, having authored 24 papers that have together received 301 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Potassium and Related Disorders (5 papers), Inhalation and Respiratory Drug Delivery (4 papers), Safe Handling of Antineoplastic Drugs (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Membrane-based Ion Separation Techniques (3 papers) and Respiratory Support and Mechanisms (3 papers). The work is most often cited by research in Family Practice (16 citations), Physiology (175 citations), Pulmonary and Respiratory Medicine (199 citations), Geriatrics and Gerontology (22 citations) and Immunology and Allergy (18 citations). Jill Davis has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Frank Trudo, Ozgur Tunceli, David M. Kern, Bingcao Wu, Setareh A. Williams, Charlie Strange, David Price, Jaco Voorham, Xiao Xu and Joanna Ling. Their work appears in journals such as Advances in Therapy, International Journal of COPD, Journal of Managed Care & Specialty Pharmacy, Journal of Pharmacy Practice and Research and Clinical Kidney Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact